Evolution of Dupilumab-Associated Cutaneous Atypical Lymphoid Infiltrates

Abstract

These cases highlight the transformation of lymphoid infiltrates after dupilumab treatment for AD and emphasize the importance of clinical and histopathologic evaluation before and during treatment with dupilumab for treatment-refractory presumed AD.